Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

DTaP poliovirus vaccine - Sanofi Pasteur

Next Previous
Drug Profile

DTaP poliovirus vaccine - Sanofi Pasteur

Alternative Names: DTacP-IPV combined vaccine - Sanofi; Tetravac; Tetraxim

Latest Information Update: 04 Apr 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Aventis Pasteur (now called sanofi pasteur)
  • Developer Sanofi; Sanofi Pasteur
  • Class Bacterial vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Pertussis; Poliomyelitis; Tetanus

Most Recent Events

  • 03 Mar 2014 Launched prior to 2014 for Diphtheria (prevention, in infants and children) in Argentina, Austria, Belgium, Finland, France, Germany, Greece, Italy, Hong Kong, Hungary, Ireland, Malaysia, Norway, Philippines, Portugal, South Africa, South Korea, Switzerland, Thailand, Turkey and the United Kingdom (IM)
  • 03 Mar 2014 Launched prior to 2014 for Tetanus (prevention, in infants and children) in Argentina, Austria, Belgium, Finland, France, Germany, Greece, Italy, Hong Kong, Hungary, Ireland, Malaysia, Norway, Philippines, Portugal, South Africa, South Korea, Switzerland, Thailand, Turkey and the United Kingdom (IM)
  • 03 Mar 2014 Launched prior to 2014 for Pertussis (prevention, in infants and children) in Argentina, Austria, Belgium, Finland, France, Germany, Greece, Italy, Hong Kong, Hungary, Ireland, Malaysia, Norway, Philippines, Portugal, South Africa, South Korea, Switzerland, Thailand, Turkey and the United Kingdom (IM)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top